Memantine Merz (Memantine Hydrochloride)

Memantine works by binding to the NMDA‑type glutamate receptor as a non‑competitive antagonist. This blocks excessive calcium entry that occurs during prolonged glutamate stimulation, reducing excitotoxic neuronal damage while allowing normal synaptic activity to continue, which supports neuronal health in Alzheimer‑related brain regions.

The dosing regimen for Memantine Merz is determined by the prescribing clinician based on the individual’s clinical status, renal function, and concomitant therapies. Physicians typically start with a low dose and titrate upward as tolerated, but the exact schedule should follow the prescriber’s instructions and local labeling.

Safety data for memantine in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Healthcare providers should evaluate the potential benefits against possible risks before prescribing to pregnant or nursing women, and alternative therapies may be considered.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and the necessary import documentation.

The primary alternative class for Alzheimer’s disease is cholinesterase inhibitors such as donepezil. While cholinesterase inhibitors increase acetylcholine levels, memantine modulates glutamatergic excitotoxicity via NMDA‑receptor blockade. Both classes can be used together to target different pathogenic pathways, offering complementary benefits in many patients.

Memantine Merz should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product away from extreme heat or humidity, and ensure the container is tightly closed when not in use.

Memantine Merz is supplied as an oral tablet and is taken by mouth, usually with or without food. Patients should swallow the tablet whole with a glass of water and follow the dosing schedule prescribed by their healthcare professional.

Serious adverse events, although rare, include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, seizures, and marked hypertension. Prompt medical attention is required if any of these symptoms develop, and the medication should be discontinued under professional guidance.

Memantine Merz is contraindicated in patients with known hypersensitivity to memantine or any excipients in the formulation. Caution is also advised for individuals with severe renal impairment, uncontrolled hypertension, or a history of seizures, and it should be avoided in combination with other NMDA antagonists.